company background image
TSPC

Tempo Scan Pacific IDX:TSPC Stock Report

Last Price

Rp1.45k

Market Cap

Rp6.5t

7D

-1.4%

1Y

-2.7%

Updated

21 May, 2022

Data

Company Financials
TSPC fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends3/6

TSPC Stock Overview

PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally.

Tempo Scan Pacific Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tempo Scan Pacific
Historical stock prices
Current Share PriceRp1,445.00
52 Week HighRp1,790.00
52 Week LowRp1,420.00
Beta0.64
1 Month Change-1.70%
3 Month Change-4.93%
1 Year Change-2.69%
3 Year Change-9.40%
5 Year Change-29.51%
Change since IPO201.04%

Recent News & Updates

Shareholder Returns

TSPCID PharmaceuticalsID Market
7D-1.4%1.7%3.1%
1Y-2.7%0.5%18.2%

Return vs Industry: TSPC underperformed the ID Pharmaceuticals industry which returned 0.5% over the past year.

Return vs Market: TSPC underperformed the ID Market which returned 18.2% over the past year.

Price Volatility

Is TSPC's price volatile compared to industry and market?
TSPC volatility
TSPC Average Weekly Movement1.1%
Pharmaceuticals Industry Average Movement3.7%
Market Average Movement6.2%
10% most volatile stocks in ID Market12.1%
10% least volatile stocks in ID Market3.0%

Stable Share Price: TSPC is less volatile than 75% of ID stocks over the past 3 months, typically moving +/- 1% a week.

Volatility Over Time: TSPC's weekly volatility (1%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19704,725I Made Wijayahttps://www.temposcangroup.com

PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through three segments: Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and beverages, and plastic packaging; and manufacturing and trading of consumer products, cosmetics, and household products.

Tempo Scan Pacific Fundamentals Summary

How do Tempo Scan Pacific's earnings and revenue compare to its market cap?
TSPC fundamental statistics
Market CapRp6.52t
Earnings (TTM)Rp823.77b
Revenue (TTM)Rp11.23t

7.9x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
TSPC income statement (TTM)
RevenueRp11.23t
Cost of RevenueRp7.26t
Gross ProfitRp3.98t
Other ExpensesRp3.16t
EarningsRp823.77b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)182.66
Gross Margin35.42%
Net Profit Margin7.33%
Debt/Equity Ratio11.6%

How did TSPC perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

44%

Payout Ratio

Valuation

Is Tempo Scan Pacific undervalued compared to its fair value and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


7.91x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: TSPC (IDR1445) is trading above our estimate of fair value (IDR816.99)

Significantly Below Fair Value: TSPC is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: TSPC is good value based on its PE Ratio (7.9x) compared to the ID Pharmaceuticals industry average (20.7x).

PE vs Market: TSPC is good value based on its PE Ratio (7.9x) compared to the ID market (18.5x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate TSPC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: TSPC is good value based on its PB Ratio (1x) compared to the ID Pharmaceuticals industry average (2.5x).


Future Growth

How is Tempo Scan Pacific forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


15.7%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Tempo Scan Pacific has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Tempo Scan Pacific performed over the past 5 years?

Past Performance Score

3/6

Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


10.5%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: TSPC has high quality earnings.

Growing Profit Margin: TSPC's current net profit margins (7.3%) are higher than last year (7.2%).


Past Earnings Growth Analysis

Earnings Trend: TSPC's earnings have grown by 10.5% per year over the past 5 years.

Accelerating Growth: TSPC's earnings growth over the past year (4.6%) is below its 5-year average (10.5% per year).

Earnings vs Industry: TSPC earnings growth over the past year (4.6%) underperformed the Pharmaceuticals industry 11.7%.


Return on Equity

High ROE: TSPC's Return on Equity (12.8%) is considered low.


Financial Health

How is Tempo Scan Pacific's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: TSPC's short term assets (IDR6,239.0B) exceed its short term liabilities (IDR1,895.3B).

Long Term Liabilities: TSPC's short term assets (IDR6,239.0B) exceed its long term liabilities (IDR873.8B).


Debt to Equity History and Analysis

Debt Level: TSPC has more cash than its total debt.

Reducing Debt: TSPC's debt to equity ratio has increased from 3.6% to 11.6% over the past 5 years.

Debt Coverage: TSPC's debt is well covered by operating cash flow (86.7%).

Interest Coverage: TSPC earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Tempo Scan Pacific current dividend yield, its reliability and sustainability?

Dividend Score

2/6

Dividend Score 2/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


2.77%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: TSPC's dividend (2.77%) is higher than the bottom 25% of dividend payers in the ID market (1.13%).

High Dividend: TSPC's dividend (2.77%) is low compared to the top 25% of dividend payers in the ID market (4.15%).


Stability and Growth of Payments

Stable Dividend: TSPC's dividend payments have been volatile in the past 10 years.

Growing Dividend: TSPC's dividend payments have fallen over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (43.7%), TSPC's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonable cash payout ratio (59.4%), TSPC's dividend payments are covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

4.9yrs

Average management tenure


CEO

I Made Wijaya (51 yo)

1.33yrs

Tenure

Mr. I Made Dharma Wijaya had been President Director of PT Tempo Scan Pacific Tbk since 2021 and has been its Director of PT Tempo Scan Pacific Tbk since 2018 and serves as its Managing Director of Sales &...


Leadership Team

Experienced Management: TSPC's management team is considered experienced (4.9 years average tenure).


Board Members

Experienced Board: TSPC's board of directors are considered experienced (5.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

PT Tempo Scan Pacific Tbk's employee growth, exchange listings and data sources


Key Information

  • Name: PT Tempo Scan Pacific Tbk
  • Ticker: TSPC
  • Exchange: IDX
  • Founded: 1970
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: Rp6.517t
  • Shares outstanding: 4.51b
  • Website: https://www.temposcangroup.com

Number of Employees


Location

  • PT Tempo Scan Pacific Tbk
  • Tempo Scan Tower
  • 16th Floor
  • Jakarta
  • Jakarta Raya
  • 12950
  • Indonesia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/21 00:00
End of Day Share Price2022/05/20 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.